Cladribine and Ocrelizumab induce differentially modulated microRNA profiles in mononucleated blood cells from relapsing-remitting Multiple Sclerosis patients

被引：0

作者：

Arisi, Ivan ^{[1
]}

Malimpensa, Leonardo ^{[2
]}

Manzini, Valeria ^{[2
]}

Brandi, Rossella ^{[3
]}

D'Amelio, Chiara ^{[4
]}

di Sturmeck, Tommaso Gosetti ^{[1
]}

Crisafulli, Sebastiano ^{[5
]}

Ferrazzano, Gina ^{[2
]}

Belvisi, Daniele ^{[2
]}

Malerba, Francesca ^{[1
]}

Florio, Rita ^{[1
]}

Pascale, Esterina ^{[2
]}

Soreq, Hermona ^{[6
,7
]}

Salvetti, Marco ^{[2
]}

Cattaneo, Antonino ^{[1
]}

D'Onofrio, Mara ^{[1
]}

Conte, Antonella ^{[2
]}

机构：

[1] EBRI, European Brain Res Inst Rita Levi Montalcini, Rome, Italy

[2] Univ Roma La Sapienza, Rome, Italy

[3] Sci Dept Army Med Ctr, Rome, Italy

[4] Univ Cattolica Sacro Cuore, Rome, Italy

[5] Multiple Sclerosis Ctr, Milan, Italy

[6] Hebrew Univ Jersusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel

[7] Hebrew Univ Jersusalem, Inst Life Sci, Jerusalem, Israel

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1415/1877

引用

页码：902 / 902

页数：1

共 50 条

[41] Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Michels, Renee Else
de Fransesco, Maria
Mahajan, Koshu
Hengstman, Gerald J. D.
Schiffers, Krijn M. H.
Budhia, Sangeeta
Harty, Gerard
Krol, Marieke
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2019, 17 (06) : 857 - 873
[42] Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients
Golabi, Marjan
Fathi, Farshid
Samadi, Morteza
Hesamian, Mohammad Sadegh
Eskandari, Nahid
INFLAMMATION, 2022, 45 (04) : 1815 - 1828
[43] Cognitive impairment in patients with relapsing-remitting multiple sclerosis
Mendes, M. F.
Balsimelli, S.
Tilbery, C. P.
MULTIPLE SCLEROSIS, 2006, 12 : S142 - S142
[44] Cardiovascular abnormalities in patients with relapsing-remitting multiple sclerosis
El-Ghoneimy, Lobna Ahmed Talaat
Shalaby, Nevin
Elmazny, Alaa
El-Baghdady, Yasser
Shehata, Hatem
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP3 - NP3
[45] The incidence of infusion associated reactions in Ocrelizumab-treated Relapsing-Remitting Multiple Sclerosis patients.
Bewick, C.
Das, E.
Collins, J.
Nash, C.
Fisniku, L.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 684 - 684
[46] Cognitive impairment in relapsing-remitting multiple sclerosis patients
Altinkaya, A.
Ozcan, E.
Yandim-Kuscu, D.
Kurt, E.
Bingol, A.
Kirbas, D.
Topcular, B.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
[47] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
Navarro-Lopez, V.
Mingot, J. M.
Carrion-Gutierrez, M.
Paya-Espinosa, Y.
Ruzafa Costa, B.
Nunez Delegido, E.
ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
[48] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
Onder, Halil
TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
[49] Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
Nocentini, U
Pasqualetti, P
Bonavita, S
Buccafusca, M
De Caro, MF
Farina, D
Girlanda, P
Le Pira, F
Lugaresi, A
Quattrone, A
Reggio, A
Salemi, G
Savettieri, G
Tedeschi, G
Trojano, M
Valentino, P
Caltagirone, C
MULTIPLE SCLEROSIS, 2006, 12 (01): : 77 - 87
[50] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
Tomaž Omerzu
Jožef Magdič
Radovan Hojs
Uroš Potočnik
Mario Gorenjak
Tanja Hojs Fabjan
Wiener klinische Wochenschrift, 2024, 136 : 40 - 47

← 1 2 3 4 5 →